OMERS ADMINISTRATION Corp lifted its position in shares of Cigna Group (NYSE:CI – Free Report) by 25.2% during the first quarter, Holdings Channel reports. The firm owned 13,052 shares of the health services provider’s stock after acquiring an additional 2,628 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in Cigna Group were worth $3,482,000 as of its most recent filing with the SEC.
A number of other large investors have also recently made changes to their positions in the company. Norges Bank purchased a new position in Cigna Group during the 4th quarter worth approximately $1,019,790,000. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Cigna Group by 13,333.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock valued at $900,912,000 after acquiring an additional 3,141,844 shares during the period. Dodge & Cox grew its position in shares of Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after acquiring an additional 1,833,389 shares during the last quarter. Boston Partners grew its position in shares of Cigna Group by 314.6% during the fourth quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock worth $450,856,000 after acquiring an additional 1,243,056 shares during the last quarter. Finally, GQG Partners LLC increased its holdings in shares of Cigna Group by 14.3% in the 4th quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock valued at $2,136,699,000 after acquiring an additional 972,302 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.
Cigna Group Price Performance
Cigna Group stock opened at $291.35 on Tuesday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The business has a 50 day simple moving average of $286.15 and a 200-day simple moving average of $280.80. The stock has a market capitalization of $77.07 billion, a PE ratio of 12.35, a price-to-earnings-growth ratio of 1.12 and a beta of 0.29.
Cigna Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is 26.45%.
Insider Activity
In other news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Several analysts recently commented on the stock. The Goldman Sachs Group upped their price target on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Morgan Stanley lifted their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research note on Wednesday, May 20th. Wolfe Research reaffirmed an “outperform” rating and issued a $315.00 target price on shares of Cigna Group in a report on Tuesday, June 16th. Robert W. Baird set a $337.00 target price on shares of Cigna Group in a research note on Friday, May 1st. Finally, Jefferies Financial Group lowered their price target on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and an average price target of $338.80.
View Our Latest Analysis on CI
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Recommended Stories
- Five stocks we like better than Cigna Group
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
